Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 28, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

Which patents cover Oxybutynin, and what generic Oxybutynin alternatives are available?

Oxybutynin is a drug marketed by Barr Labs Div Teva, Mylan, Osmotica Pharm Us, Amneal Pharms, Silarx, Unique Pharm Labs, Usl Pharma, Pharm Assoc, Accord Hlthcare, Mikart, Mylan Pharms Inc, Impax Pharms, Teva Pharms Usa, Wockhardt, Vintage Pharms, Watson Labs, Quantum Pharmics, and Apotex Inc. and is included in twenty NDAs.

The generic ingredient in OXYBUTYNIN is oxybutynin chloride. There are sixteen drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the oxybutynin chloride profile page.

Summary for Tradename: OXYBUTYNIN

Bulk Api Vendors: see list51
Clinical Trials: see list32
Patent Applications: see list2,951
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:OXYBUTYNIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vintage Pharms
oxybutynin chloride
SYRUP;ORAL076682-001Dec 28, 2004AARXNoNo► Subscribe► Subscribe
Watson Labs
oxybutynin chloride
TABLET;ORAL072485-001Apr 19, 1989DISCNNoNo► Subscribe► Subscribe
Barr Labs Div Teva
FILM, EXTENDED RELEASE;TRANSDERMAL090526-001Mar 4, 2014ABRXNoNo► Subscribe► Subscribe
oxybutynin chloride
SYRUP;ORAL075039-001Jan 29, 1999DISCNNoNo► Subscribe► Subscribe
Usl Pharma
oxybutynin chloride
TABLET;ORAL070746-001Mar 10, 1988DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Analyze global market entry opportunities
  • Identify first generic entrants

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus